405 related articles for article (PubMed ID: 32708743)
1. Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study.
Sainz T; Gosalbes MJ; Talavera-Rodríguez A; Jimenez-Hernandez N; Prieto L; Escosa L; Guillén S; Ramos JT; Muñoz-Fernández MÁ; Moya A; Navarro ML; Mellado MJ; Serrano-Villar S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708743
[TBL] [Abstract][Full Text] [Related]
2. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.
Serrano-Villar S; Vázquez-Castellanos JF; Vallejo A; Latorre A; Sainz T; Ferrando-Martínez S; Rojo D; Martínez-Botas J; Del Romero J; Madrid N; Leal M; Mosele JI; Motilva MJ; Barbas C; Ferrer M; Moya A; Moreno S; Gosalbes MJ; Estrada V
Mucosal Immunol; 2017 Sep; 10(5):1279-1293. PubMed ID: 28000678
[TBL] [Abstract][Full Text] [Related]
3. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
[TBL] [Abstract][Full Text] [Related]
4. Effects of HIV, antiretroviral therapy and prebiotics on the active fraction of the gut microbiota.
Deusch S; Serrano-Villar S; Rojo D; Martínez-Martínez M; Bargiela R; Vázquez-Castellanos JF; Sainz T; Barbas C; Moya A; Moreno S; Gosalbes MJ; Estrada V; Seifert J; Ferrer M
AIDS; 2018 Jun; 32(10):1229-1237. PubMed ID: 29683848
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial.
Sainz T; Diaz L; Rojo D; Clemente MI; Barbas C; Gosalbes MJ; Jimenez-Hernandez N; Escosa L; Guillen S; Ramos JT; Muñoz-Fernández MÁ; Navarro ML; Mellado MJ; Serrano-Villar S
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267967
[TBL] [Abstract][Full Text] [Related]
7. Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study).
Serrano-Villar S; de Lagarde M; Vázquez-Castellanos J; Vallejo A; Bernadino JI; Madrid N; Matarranz M; Díaz-Santiago A; Gutiérrez C; Cabello A; Villar-García J; Blanco JR; Bisbal O; Sainz T; Moya A; Moreno S; Gosalbes MJ; Estrada V
Clin Infect Dis; 2019 Jan; 68(1):120-130. PubMed ID: 29788075
[TBL] [Abstract][Full Text] [Related]
8. Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients.
Xie X; He Y; Li H; Yu D; Na L; Sun T; Zhang D; Shi X; Xia Y; Jiang T; Rong S; Yang S; Ma X; Xu G
Nutrition; 2019 May; 61():132-142. PubMed ID: 30711862
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Saliva Microbiota through Prebiotic Intervention in HIV-Infected Individuals.
Jiménez-Hernández N; Serrano-Villar S; Domingo A; Pons X; Artacho A; Estrada V; Moya A; Gosalbes MJ
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31208015
[TBL] [Abstract][Full Text] [Related]
10. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
[TBL] [Abstract][Full Text] [Related]
11. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.
Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS
Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110
[TBL] [Abstract][Full Text] [Related]
12. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
[TBL] [Abstract][Full Text] [Related]
13. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
Bandera A; De Benedetto I; Bozzi G; Gori A
Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the intestinal microbiota in MSM with HIV infection.
Fu Y; Ke S; Tang G; Guo Q; Guo Q; Wang Z; Leng R; Fan Y
BMC Microbiol; 2024 Jun; 24(1):192. PubMed ID: 38831399
[TBL] [Abstract][Full Text] [Related]
15. Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers.
Sessa L; Reddel S; Manno E; Quagliariello A; Cotugno N; Del Chierico F; Amodio D; Capponi C; Leone F; Bernardi S; Rossi P; Putignani L; Palma P
AIDS; 2019 May; 33(6):1001-1011. PubMed ID: 30946154
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
17. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.
Ceccarelli G; Brenchley JM; Cavallari EN; Scheri GC; Fratino M; Pinacchio C; Schietroma I; Fard SN; Scagnolari C; Mezzaroma I; Vullo V; d'Ettorre G
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29160817
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of
Marißen J; Haiß A; Meyer C; Van Rossum T; Bünte LM; Frommhold D; Gille C; Goedicke-Fritz S; Göpel W; Hudalla H; Pagel J; Pirr S; Siller B; Viemann D; Vens M; König I; Herting E; Zemlin M; Gehring S; Bork P; Henneke P; Härtel C;
BMJ Open; 2019 Nov; 9(11):e032617. PubMed ID: 31753895
[TBL] [Abstract][Full Text] [Related]
19. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
Rutten NB; Gorissen DM; Eck A; Niers LE; Vlieger AM; Besseling-van der Vaart I; Budding AE; Savelkoul PH; van der Ent CK; Rijkers GT
PLoS One; 2015; 10(9):e0137681. PubMed ID: 26378926
[TBL] [Abstract][Full Text] [Related]
20. Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder.
Wang Y; Li N; Yang JJ; Zhao DM; Chen B; Zhang GQ; Chen S; Cao RF; Yu H; Zhao CY; Zhao L; Ge YS; Liu Y; Zhang LH; Hu W; Zhang L; Gai ZT
Pharmacol Res; 2020 Jul; 157():104784. PubMed ID: 32305492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]